Mutabilis
Paris
About Mutabilis
Mutabilis is discovery of new therapeutic targets for the development of anti-infectives. Mutabilis is a biopharmaceutical company specialised in the discovery and development of anti-infectives. Mutabilis discovers and develops innovative anti-infectives, a novel class of drug addressing the current issues arising from resistance to antibiotics and targeting severe bacterial infections. Mutabilis’ new therapies target nosocomial infections in particular.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $14.2M
- Funding stage: M&A
- Last round: Grant (Sep 2020)
- Website: mutabilis.fr
- Phone: +33 1 57 14 05 20
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/mutabilis-84715 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.